Non-Hodgkin Lymphoma News

Legend Biotech Receives FDA IND Clearance for LB2501, a CD19/CD20 In Vivo CAR-T Therapy - Oncodaily

Legend Biotech Receives FDA IND Clearance for LB2501, a CD19/CD20 In Vivo CAR-T Therapy Oncodaily

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial - Nature

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial Nature

Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - BioSpace

Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma BioSpace

Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference - Health.com

Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference Health.com

Beyond the Nodes: Atypical Presentations of Non-Hodgkin's Lymphoma Across Organs - Cureus

Beyond the Nodes: Atypical Presentations of Non-Hodgkin's Lymphoma Across Organs Cureus

Subcutaneous Mosunetuzumab-Polatuzumab May Widen Access in R/R LBCL - The American Journal of Managed Care

Subcutaneous Mosunetuzumab-Polatuzumab May Widen Access in R/R LBCL The American Journal of Managed Care

Study reveals promising new therapy for non-Hodgkin lymphoma - Medical Xpress

Study reveals promising new therapy for non-Hodgkin lymphoma Medical Xpress

Expanding the Role of Immunotherapy in Lymphoma - Targeted Oncology

Expanding the Role of Immunotherapy in Lymphoma Targeted Oncology

Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies - Frontiers

Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies Frontiers

Camp Lejeune Lawsuit News and Updates - Lawsuit Information Center

Camp Lejeune Lawsuit News and Updates Lawsuit Information Center

Mosunetuzumab With Response-Adapted Therapy in Previously Untreated NHL - The ASCO Post

Mosunetuzumab With Response-Adapted Therapy in Previously Untreated NHL The ASCO Post

Advances in lymphoma treatment: new therapies and clinical trials - Penn Medicine

Advances in lymphoma treatment: new therapies and clinical trials Penn Medicine

Maesteg teen whose cancer returned after remission has clinical trial hope - BBC

Maesteg teen whose cancer returned after remission has clinical trial hope BBC

New long-term analysis suggests follicular lymphoma can be cured - Fred Hutchinson Cancer Center

New long-term analysis suggests follicular lymphoma can be cured Fred Hutchinson Cancer Center

Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates - Iowa Capital Dispatch

Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates Iowa Capital Dispatch

7 Signs of Non-Hodgkin Lymphoma You Shouldn’t Ignore - Hartford HealthCare

7 Signs of Non-Hodgkin Lymphoma You Shouldn’t Ignore Hartford HealthCare

National Poetry Month: "Non-Hodgkin’s Lymphoma" - The Rumpus

National Poetry Month: "Non-Hodgkin’s Lymphoma" The Rumpus

Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts - Nature

Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts Nature

CD20-Positive B-Cell Non-Hodgkin Lymphoma Associated With Recurrent Acute Pancreatitis, Bilateral Renal Lesions, and Retroperitoneal Lymphadenopathy - Cureus

CD20-Positive B-Cell Non-Hodgkin Lymphoma Associated With Recurrent Acute Pancreatitis, Bilateral Renal Lesions, and Retroperitoneal Lymphadenopathy Cureus

Ureteral Involvement in Non-Hodgkin Lymphoma: A Rare Case Report With Diagnostic Challenges - Cureus

Ureteral Involvement in Non-Hodgkin Lymphoma: A Rare Case Report With Diagnostic Challenges Cureus

Sweet November Cancer Explained: Keanu Reeves, Charlize Theron and Sara’s Non-Hodgkin Lymphoma - Oncodaily

Sweet November Cancer Explained: Keanu Reeves, Charlize Theron and Sara’s Non-Hodgkin Lymphoma Oncodaily

Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma: From Clinical Trials to Clinical Practice - Journal of Nuclear Medicine

Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma: From Clinical Trials to Clinical Practice Journal of Nuclear Medicine

Non-Hodgkin’s lymphoma presenting as a retroperitoneal mass in the emergency department: a case report - Frontiers

Non-Hodgkin’s lymphoma presenting as a retroperitoneal mass in the emergency department: a case report Frontiers

Primary classical Hodgkin lymphoma of breast presenting as recurrent breast abscess in a non-lactating woman: a case report and literature review - Frontiers

Primary classical Hodgkin lymphoma of breast presenting as recurrent breast abscess in a non-lactating woman: a case report and literature review Frontiers

The Evolving Roles of MRD and Molecular Genotyping in Non-Hodgkin Lymphoma - CancerNetwork

The Evolving Roles of MRD and Molecular Genotyping in Non-Hodgkin Lymphoma CancerNetwork

Dave Coulier doing 'really well' after battling cancer - Yahoo Lifestyle Canada

Dave Coulier doing 'really well' after battling cancer Yahoo Lifestyle Canada

Rethinking Dual Targeting, Durability After CAR-T in Non-Hodgkin Lymphoma - CancerNetwork

Rethinking Dual Targeting, Durability After CAR-T in Non-Hodgkin Lymphoma CancerNetwork

Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin’s lymphoma - Nature

Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin’s lymphoma Nature

FDA Orphan Drug Status Awarded to EO2463 in Indolent Non-Hodgkin Lymphoma - Targeted Oncology

FDA Orphan Drug Status Awarded to EO2463 in Indolent Non-Hodgkin Lymphoma Targeted Oncology

Dave Coulier Receives Loud Cheers From Hockey Fans During NHL Cancer Awareness Night - Parade Magazine

Dave Coulier Receives Loud Cheers From Hockey Fans During NHL Cancer Awareness Night Parade Magazine

Dural Follicular Non-Hodgkin Lymphoma Mimicking a Chronic Subdural Hematoma: A Case Report and Literature Review - Cureus

Dural Follicular Non-Hodgkin Lymphoma Mimicking a Chronic Subdural Hematoma: A Case Report and Literature Review Cureus

Editorial: New molecular targets for personalized treatment for low-grade non-hodgkin lymphoma - Frontiers

Editorial: New molecular targets for personalized treatment for low-grade non-hodgkin lymphoma Frontiers

Metachronous multiple primary cancers involving pulmonary non-Hodgkin lymphoma and bladder cancer: a case report - Frontiers

Metachronous multiple primary cancers involving pulmonary non-Hodgkin lymphoma and bladder cancer: a case report Frontiers

Non-Hodgkin's Lymphoma Market Size to Hit USD 26.22 Billion by 2035 - Precedence Research

Non-Hodgkin's Lymphoma Market Size to Hit USD 26.22 Billion by 2035 Precedence Research

Current treatment algorithm: diffuse large B cell lymphoma - Blood Cancer Journal - Nature

Current treatment algorithm: diffuse large B cell lymphoma - Blood Cancer Journal Nature

Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature - Frontiers

Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature Frontiers

Primary Pulmonary Non-Hodgkin Lymphoma: A Report of Two Cases and a Review of the Literature Emphasizing the Role of Radiotherapy - Cureus

Primary Pulmonary Non-Hodgkin Lymphoma: A Report of Two Cases and a Review of the Literature Emphasizing the Role of Radiotherapy Cureus